Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1978-9-15
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Breast Cancer, http://linkedlifedata.com/resource/pubmed/keyword/Cancer, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods--side effects, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/ESTRADIOL, http://linkedlifedata.com/resource/pubmed/keyword/Endocrine System, http://linkedlifedata.com/resource/pubmed/keyword/Endometrial Effects, http://linkedlifedata.com/resource/pubmed/keyword/Endometrium, http://linkedlifedata.com/resource/pubmed/keyword/Estrogens--complications, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female, http://linkedlifedata.com/resource/pubmed/keyword/Hormones, http://linkedlifedata.com/resource/pubmed/keyword/Menopause, http://linkedlifedata.com/resource/pubmed/keyword/Menstruation Disorders, http://linkedlifedata.com/resource/pubmed/keyword/Myometrial Effects, http://linkedlifedata.com/resource/pubmed/keyword/Myometrium, http://linkedlifedata.com/resource/pubmed/keyword/Neoplasms, http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives--side effects, http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Progestational Hormones, http://linkedlifedata.com/resource/pubmed/keyword/Reproduction, http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System, http://linkedlifedata.com/resource/pubmed/keyword/Uterus, http://linkedlifedata.com/resource/pubmed/keyword/Vaginal Cancer
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
J
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0038-0814
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
23-6
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: Estrogens and progesterone seem to have at times antagonistic, at times synergetic action on breast and uterine tissues. While estrogens stimulate cell proliferation, progestrerone favors secretion. While estrogens favor myometrial and endometrial hyperplasia, progesterone seems to dominish congestive phenomena caused by estrogens, especially on breast tissues. Women who experience menopause at 55 have a twice as high risk of breast cancer than women who menopause at 45. Breast and endometrial cancer are often associated with a history of menstrual disorders, and it is very possible that endometrial hyperplasia and cystic mastosis are connected. While treatment with estrogens helps to avoid vaginal atrophy and to arrest osteoporosis, it is doubtful whether the treatment should be systematic over 45. Breast examination and a thorough gynecological examination are essential once a year.
pubmed:meshHeading
pubmed:year
1978
pubmed:articleTitle
[Menopause, estrogens and genital cancer].
pubmed:publicationType
Journal Article, English Abstract